Ixekizumab in Moderate to Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
N. Engl. J. Med 2016 Jun 08;[EPub Ahead of Print], KB Gordon, A Blauvelt, KA Papp, RG Langley, T Luger, M Ohtsuki, K Reich, D Amato, SG Ball, DK Braun, GS Cameron, J Erickson, RJ Konrad, TM Muram, BJ Nickoloff, OO Osuntokun, RJ Secrest, F Zhao, L Mallbris, CL LeonardiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.